血尿酸与高密度脂蛋白胆固醇比值在糖脂代谢相关疾病中的研究进展

doi:10.3969/j.issn.1004-583X.2022.11.015

摘要/Abstract

摘要：

血尿酸/高密度脂蛋白胆固醇比值(serum uric acid to high-density lipoprotein cholesterol ratio, UHR)作为一项能反映炎症水平和代谢状态的新型标志物,已被证实与2型糖尿病、代谢综合征、非酒精性脂肪性肝病、缺血性心肌病等糖脂代谢相关疾病及其他疾病有着不同程度的相关性,因此,本文主要阐述UHR在糖脂代谢相关疾病中的预测、诊断、评估病情控制情况的作用。

中图分类号:

R589.2

张雪晴, 陈树春. 血尿酸与高密度脂蛋白胆固醇比值在糖脂代谢相关疾病中的研究进展[J]. 临床荟萃, 2022, 37(11): 1044-1047.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2022.11.015

https://huicui.hebmu.edu.cn/CN/Y2022/V37/I11/1044

参考文献 36

[1]	Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease[J]. Cell Metab, 2011, 13(1):11-22. doi: 10.1016/j.cmet.2010.12.008 pmid: 21195345
[2]	Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease[J]. Genes Dev, 2021, 35(5-6): 307-328. doi: 10.1101/gad.346312.120 URL
[3]	Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: The abund study[J]. Rev Assoc Med Bras, 2021, 67(4): 549-554. doi: 10.1590/1806-9282.20201005 pmid: 34495059
[4]	Cao W, Zheng RD, Xu SH, et al. Association between sex hormone and blood uric acid in male patients with type 2 diabetes[J]. Int J Endocrinol, 2017, 2017: 4375253.
[5]	中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志, 2020, 36(1): 1-13.
[6]	George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress[J]. Vasc Health Risk Man, 2009, 5(1): 265-272.
[7]	Borghi C, Agnoletti D, Cicero AFG, et al. Uric acid and hypertension: A review of evidence and future perspectives for the management of cardiovascular risk[J]. Hypertension, 2022, 79(9): 1927-1936. doi: 10.1161/HYPERTENSIONAHA.122.17956 pmid: 35658505
[8]	Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: Does uric acid have a definitive role?[J]. Eur J Intern Med, 2022, 103(9): 4-12. doi: 10.1016/j.ejim.2022.04.022 URL
[9]	Hwang J, Lee MY, Ahn JK, et al. Relationship between changing body mass index and serum uric acid alteration among clinically apparently healthy Korean men[J]. Arthrit Care Res, 2022, 74(8): 1277-1286. doi: 10.1002/acr.24576 URL
[10]	Yan P, Zhang Z, Wan Q, et al. Association of serum uric acid with bone mineral density and clinical fractures in Chinese type 2 diabetes mellitus patients: A cross-sectional study[J]. Clin Chim Acta, 2018, 486(11): 76-85. doi: 10.1016/j.cca.2018.07.033 URL
[11]	Yang S, Ye Z, Liu M, et al. Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease[J]. Clin Endocrinol, 2022, 98(1): 49-58. doi: 10.1111/cen.14810 URL
[12]	Van der vorst EPC. High-density lipoproteins and apolipoprotein A1[J]. Subcell Biochem, 2020, 94: 399-420. doi: 10.1007/978-3-030-41769-7_16 pmid: 32189309
[13]	Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus[J]. Aging Male, 2020, 23(5): 1098-1102. doi: 10.1080/13685538.2019.1678126 URL
[14]	Nathan DM, Zinman B, Cleary PA, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: The diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005)[J]. Arch Intern Med, 2009, 169(14): 1307-1316. doi: 10.1001/archinternmed.2009.193 pmid: 19636033
[15]	Kowalski AJ, Dutta S. It's time to move from the A1c to better metrics for diabetes control[J]. Diabetes Technol Ther, 2013, 15(3): 194-196. doi: 10.1089/dia.2013.0060 URL
[16]	尤玉青, 李伟, 周东浩. 血尿酸/高密度脂蛋白胆固醇比值与糖尿病肾脏疾病的相关性研究[J]. 中国糖尿病杂志, 2021, 29(10): 749-753.
[17]	Cheung N, Mitchell P, Wong TY. Diabetic retinopathy[J]. Lancet, 2010, 376(9735): 124-136. doi: 10.1016/S0140-6736(09)62124-3 pmid: 20580421
[18]	Cipriani C, Colangelo L, Santori R, et al. The interplay between bone and glucose metabolism[J]. Front Endocrinol (Lausanne), 2020, 11(24): 122. doi: 10.3389/fendo.2020.00122 URL
[19]	Dhawan S, Natarajan R. Epigenetics and type 2 diabetes risk[J]. Curr Diabetes Rep, 2019, 19(8): 47. doi: 10.1007/s11892-019-1168-8 pmid: 31250127
[20]	Zhang Q, Zhou J, Wang Q, et al. Association between bone mineral density and lipid profile in Chinese women[J]. Clin Interv Aging, 2020, 15(15):1649-1664. doi: 10.2147/CIA.S266722 URL
[21]	Niu P, Li H, Liu D, et al. Association between HDL-C and bone mineral density: An cross-sectional analysis[J]. Int J Gen Med, 2021, 14(26): 8863-8872. doi: 10.2147/IJGM.S334972 URL
[22]	Tang Y, Wang S, Yi Q, et al. High-density lipoprotein cholesterol is negatively correlated with bone mineral density and has potential predictive value for bone loss[J]. Lipids Health Dis, 2021, 20(1): 75. doi: 10.1186/s12944-021-01497-7 pmid: 34304735
[23]	相爱霞, 宋勇刚, 于婷婷, 等. 2型糖尿病血清尿酸与高密度脂蛋白比值和骨代谢、骨密度和骨质疏松的相关研究[J]. 糖尿病新世界, 2022, 25(12): 26-30.
[24]	Chen YY, Kao TW, Yang HF, et al. The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects- An observational study[J]. Clin Chim Acta, 2018, 478: 68-73. doi: 10.1016/j.cca.2017.12.038 URL
[25]	Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus[J]. Rev Assoc Med Bras(1992), 2019, 65(1): 9-15.
[26]	Yazdi F, Baghaei MH, Baniasad A, et al. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome[J]. Endocrinol Diabetes Metab, 2022, 5(1): e00311.
[27]	中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 实用肝脏病杂志, 2018, 21(2): 177-186.
[28]	Hijona E, Hijona L, Arenas JI, et al. Inflammatory mediators of hepatic steatosis[J]. Mediat Inflamm, 2010, 2010: 837419.
[29]	Zhang YN, Wang QQ, Chen YS, et al. Association between serum uric acid to HDL-cholesterol ratio and nonalcoholic fatty liver disease in lean Chinese adults[J]. Int J Endocrinol, 2020, 2020: 5953461.
[30]	Sagris M, Antonopoulos AS, Theofilis P, et al. Risk factors profile of young and older patients with myocardial infarction[J]. Cardiovasc Res, 2022, 118(10): 2281-2292. doi: 10.1093/cvr/cvab264 URL
[31]	Park B, Jung DH, Lee YJ. Predictive value of serum uric acid to HDL cholesterol ratio for incident ischemic heart disease in non-diabetic Koreans[J]. Biomedicines, 2022, 10(6): 1422. doi: 10.3390/biomedicines10061422 URL
[32]	Antonelli A, Ferrari SM, Corrado A, et al. Autoimmune thyroid disorders[J]. Autoimmun Rev, 2015, 14(2): 174-180. doi: 10.1016/j.autrev.2014.10.016 pmid: 25461470
[33]	Volpé R. The pathology of thyroiditis[J]. Hum Pathol, 1978, 9(4): 429-438. pmid: 581380
[34]	Vukovic R, Zeljkovic A, Bufan B, et al. Hashimoto thyroiditis and dyslipidemia in childhood: A review[J]. Front Endocrinol (Lausanne), 2019, 10(10): 868. doi: 10.3389/fendo.2019.00868 URL
[35]	Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto's thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio[J]. Rom J Intern Med, 2021, 59(4): 403-408. doi: 10.2478/rjim-2021-0023 pmid: 34142519
[36]	Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: A cross-sectional cohort study[J]. Postgrad Med, 2022, 134(3): 297-302. doi: 10.1080/00325481.2022.2039007 URL

血尿酸与高密度脂蛋白胆固醇比值在糖脂代谢相关疾病中的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 36

相关文章 15

编辑推荐

Metrics

本文评价

[1]	位增, 曹灵, 佘敦敏, 刘彦, 王艳, 张真稳. 54例2型糖尿病患者合并新型冠状病毒感染的死亡原因分析[J]. 临床荟萃, 2023, 38(9): 806-812.
[2]	高士欣, 宋冰, 施克新. 血清脂蛋白α、胱抑素-C和尿酸检测对早期糖尿病肾病的诊断价值[J]. 临床荟萃, 2022, 37(3): 248-252.
[3]	郑鑫，朱育刚，王德峰. GLP-1受体激动剂对超重及肥胖2型糖尿病患者胰岛细胞功能影响的系统评价[J]. 临床荟萃, 2019, 34(12): 1102-1107.
[4]	何欢1，2, 郅敏3, 4. 炎症性肠病与营养治疗[J]. 临床荟萃, 2018, 33(8): 666-669.
[5]	田雨，李俊霞，王化虹. 炎症性肠病的营养相关疾病[J]. 临床荟萃, 2018, 33(8): 656-660.
[6]	冯忠军1，张淑兰2. 脑钠肽临床应用现状[J]. 临床荟萃, 2017, 32(4): 287-290.
[7]	王晓晶，肖新华. 2型糖尿病口服降糖药治疗[J]. 临床荟萃, 2016, 31(9): 939-943.
[8]	张颖超;崔丽梅. 719例北京市近郊居民代谢综合征现状分析[J]. 临床荟萃, 2006, 21(16): 1175-1176.
[9]	韩学尧;纪立农. 早发2型糖尿病家系一级亲属血清尿酸水平的横断面研究[J]. 临床荟萃, 2005, 20(8): 421-425.
[10]	张巧;胡颖;双倩. 心理性胰岛素抵抗的相关因素分析[J]. 临床荟萃, 2005, 20(19): 1111-1112.
[11]	孙奥丽;孙永波;孙艳玲. 血管紧张素转换酶抑制剂与2型糖尿病及并发症[J]. 临床荟萃, 2004, 19(23): 1372-1374.
[12]	姚伟峰;黄雌友. 胰岛素泵强化治疗对初诊2型糖尿病患者胰岛β细胞功能及C-反应蛋白的影响[J]. 临床荟萃, 2004, 19(23): 1354-1355.
[13]	白玉云;杨少清;张发成;李月惠;王秀芝. 辛伐他汀对非高脂血症2型糖尿病患者一氧化氮和C反应蛋白的影响[J]. 临床荟萃, 2004, 19(23): 1328-1330.
[14]	邓幼平;徐焱成;张颖. 蛋白酪氨酸磷酸酶-1B基因多态性与2型糖尿病的相关性研究[J]. 临床荟萃, 2003, 18(9): 481-484.
[15]	黄萍;陈桂丽;刘霞. 2型糖尿病患者大血管病变与C反应蛋白的相关性研究[J]. 临床荟萃, 2003, 18(23): 1328-1330.